Search research articles
Contact Us
Filters
Showing results (141-150 of 241) with videos related to
Page
of 25
Sort By:
European Journal of Cancer (Oxford, England : 1990)
|
December 3, 2014
Bevacizumab combined with 5-FU/streptozocin in patients with progressive metastatic well-differentiated pancreatic endocrine tumours (BETTER trial)--a phase II non-randomised trial
Michel Ducreux, Laetitia Dahan, Denis Smith, et al.
Thyroid : Official Journal of the American Thyroid Association
|
October 29, 2025
Validation of the International Medullary Thyroid Carcinoma Grading System in Patients with Distant Metastases
Tommaso Porcelli, Sophie Moog, Mohamed-Amine Bani, et al.
Thyroid : Official Journal of the American Thyroid Association
|
September 12, 2023
Alkylating Agent-Induced High Tumor Mutational Burden in Medullary Thyroid Cancer and Response to Immune Checkpoint Inhibitors: Two Case Reports
Sophie Moog, Livia Lamartina, Mohamed-Amine Bani, et al.
The Journal of Clinical Endocrinology and Metabolism
|
August 30, 2007
Imaging medullary thyroid carcinoma with persistent elevated calcitonin levels
Anne Laure Giraudet, Daniel Vanel, Sophie Leboulleux, et al.
European Journal of Nuclear Medicine and Molecular Imaging
|
February 17, 2020
Lessons from a multicentre retrospective study of peptide receptor radionuclide therapy combined with lanreotide for neuroendocrine tumours: a need for standardised practice
Vikas Prasad, Raj Srirajaskanthan, Christos Toumpanakis, et al.
European Journal of Endocrinology
|
January 16, 2014
Tyrosine kinase inhibitor treatments in patients with metastatic thyroid carcinomas: a retrospective study of the TUTHYREF network
Marie-Hélène Massicotte, Maryse Brassard, Médéric Claude-Desroches, et al.
European Journal of Cancer (Oxford, England : 1990)
|
June 5, 2023
Outcome of adrenocortical carcinoma patients included in early phase clinical trials: Results from the French network ENDOCAN-COMETE
Ségolène Hescot, Véronique Debien, Julien Hadoux, et al.
European Journal of Endocrinology
|
December 23, 2011
Phase II study of weekly paclitaxel and sorafenib as second/third-line therapy in patients with adrenocortical carcinoma
Alfredo Berruti, Paola Sperone, Anna Ferrero, et al.
Presse Medicale (Paris, France : 1983)
|
May 27, 2014
[Malignant insulinoma: recommendations for workup and treatment]
Eric Baudin, Philippe Caron, Catherine Lombard-Bohas, et al.
Lancet (London, England)
|
November 29, 2011
Everolimus plus octreotide long-acting repeatable for the treatment of advanced neuroendocrine tumours associated with carcinoid syndrome (RADIANT-2): a randomised, placebo-controlled, phase 3 study
Marianne E Pavel, John D Hainsworth, Eric Baudin, et al.
Page
of 25
Search research articles
Search
Showing results (141-150 of 241) with videos related to
Sort By:
Page
of 25
European Journal of Cancer (Oxford, England : 1990)
|
December 3, 2014
Bevacizumab combined with 5-FU/streptozocin in patients with progressive metastatic well-differentiated pancreatic endocrine tumours (BETTER trial)--a phase II non-randomised trial
Michel Ducreux, Laetitia Dahan, Denis Smith, et al.
Thyroid : Official Journal of the American Thyroid Association
|
October 29, 2025
Validation of the International Medullary Thyroid Carcinoma Grading System in Patients with Distant Metastases
Tommaso Porcelli, Sophie Moog, Mohamed-Amine Bani, et al.
Thyroid : Official Journal of the American Thyroid Association
|
September 12, 2023
Alkylating Agent-Induced High Tumor Mutational Burden in Medullary Thyroid Cancer and Response to Immune Checkpoint Inhibitors: Two Case Reports
Sophie Moog, Livia Lamartina, Mohamed-Amine Bani, et al.
The Journal of Clinical Endocrinology and Metabolism
|
August 30, 2007
Imaging medullary thyroid carcinoma with persistent elevated calcitonin levels
Anne Laure Giraudet, Daniel Vanel, Sophie Leboulleux, et al.
European Journal of Nuclear Medicine and Molecular Imaging
|
February 17, 2020
Lessons from a multicentre retrospective study of peptide receptor radionuclide therapy combined with lanreotide for neuroendocrine tumours: a need for standardised practice
Vikas Prasad, Raj Srirajaskanthan, Christos Toumpanakis, et al.
European Journal of Endocrinology
|
January 16, 2014
Tyrosine kinase inhibitor treatments in patients with metastatic thyroid carcinomas: a retrospective study of the TUTHYREF network
Marie-Hélène Massicotte, Maryse Brassard, Médéric Claude-Desroches, et al.
European Journal of Cancer (Oxford, England : 1990)
|
June 5, 2023
Outcome of adrenocortical carcinoma patients included in early phase clinical trials: Results from the French network ENDOCAN-COMETE
Ségolène Hescot, Véronique Debien, Julien Hadoux, et al.
European Journal of Endocrinology
|
December 23, 2011
Phase II study of weekly paclitaxel and sorafenib as second/third-line therapy in patients with adrenocortical carcinoma
Alfredo Berruti, Paola Sperone, Anna Ferrero, et al.
Presse Medicale (Paris, France : 1983)
|
May 27, 2014
[Malignant insulinoma: recommendations for workup and treatment]
Eric Baudin, Philippe Caron, Catherine Lombard-Bohas, et al.
Lancet (London, England)
|
November 29, 2011
Everolimus plus octreotide long-acting repeatable for the treatment of advanced neuroendocrine tumours associated with carcinoid syndrome (RADIANT-2): a randomised, placebo-controlled, phase 3 study
Marianne E Pavel, John D Hainsworth, Eric Baudin, et al.
Page
of 25